Pulsenmore Ltd PLSM

Morningstar Rating
$1.77 −0.02 (1.12%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PLSM is trading at a LOCK|&%^YW premium.
Price
$1.77
Fair Value
LOCK|rLg^c<k
Uncertainty
LOCK|Sc<
1-Star Price
LOCK|t$bT&Tf
5-Star Price
LOCK|mpVTGLf
Economic Moat
LOCK|K<?&l
Capital Allocation
—

News

Trading Information

Previous Close Price
$1.78
Day Range
$1.77–1.77
52-Week Range
$1.75–12.95
Bid/Ask
$0.00 / $0.00
Shares Outstanding
6.50M
Market Cap
$0.00
Volume/Avg
1,547 / 63,080

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.87
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
63

Valuation

Metric
PLSM
Price/Earnings (Normalized)
—
Price/Book Value
0.71
Price/Sales
0.87
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
PLSM
Quick Ratio
1.69
Current Ratio
1.84
Interest Coverage
−1.67
Quick Ratio
PLSM

Profitability

Metric
PLSM
Return on Assets (Normalized)
−22.35%
Return on Equity (Normalized)
−36.93%
Return on Invested Capital (Normalized)
−22.02%
Return on Assets
PLSM

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|VMH$p^&LOCK|^N#Y>$179B
Medtronic PLC
MDT
LOCK|Fd&g>z<LOCK|HkR&<$122B
Stryker Corp
SYK
LOCK|R>t?YGsLOCK|g$^$118B
Boston Scientific Corp
BSX
LOCK|#^zTn^LOCK|b@!?F$66B
Edwards Lifesciences Corp
EW
LOCK|Zp#Rq#!LOCK|GQ&<^$51B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|QxcVTC#LOCK|k?$32B
DexCom Inc
DXCM
LOCK|Ym$RdXNwLOCK|@G#Jb$29B
Koninklijke Philips NV ADR
PHG
LOCK|k$LOCK|x<N$26B
Steris PLC
STE
LOCK|!Xd&d@LOCK|%Vn>c$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|<??!!%YLOCK|&<T$19B

Sponsor Center